This study is not yet accepting patients
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Summary
- Eligibility
- for people ages 16-30 (full criteria)
- Dates
- study startedestimated completion
- Principal Investigator
- by Kristin Cadenhead, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Lead Scientist at UCSD
- Kristin Cadenhead, MD
Dr. Kristin Cadenhead a Professor of Psychiatry at University of California San Diego and an attending physician at both the Veterans Administration and the UCSD Medical Centers. She serves as an Associate Residency Training Director for the Department of Psychiatry and a Clinical Foundations Director for the School of Medicine.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT04411225
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated